लोड हो रहा है...
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
The goal of cancer immunotherapy is to establish new or boost pre-existing anticancer immune responses that eradicate malignant cells while generating immunological memory to prevent disease relapse. Over the past few years, immunomodulatory monoclonal antibodies (mAbs) that block co-inhibitory rece...
में बचाया:
| में प्रकाशित: | Oncoimmunology |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Taylor & Francis
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5706611/ https://ncbi.nlm.nih.gov/pubmed/29209572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1371896 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|